Kezar Life Sciences, Inc.·4

Jan 8, 5:10 PM ET

Goel Niti 4

4 · Kezar Life Sciences, Inc. · Filed Jan 8, 2019

Insider Transaction Report

Form 4
Period: 2019-01-06
Goel Niti
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-01-06+75,00075,000 total
    Exercise: $22.85Exp: 2029-01-05Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on February 6, 2019, subject to the Reporting Person continuing to provide service through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION